http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
소라페닙 치료 실패 후 세포독성화학요법으로 완전반응을 보인 폐전이를 동반한 간세포암 1예
박화선 ( Hwa-sun Park ),장재영 ( Jae Young Jang ),백민영 ( Min Young Baek ),김용권 ( Yong Kwon Kim ),윤현진 ( Hyun Jin Youn ),백수영 ( Su Young Back ),정승원 ( Soung Won Jeong ),이세환 ( Sae Hwan Lee ),김상균 ( Sang Gyune Kim ) 대한간암학회 2017 대한간암학회지 Vol.17 No.1
Hepatocellular carcinoma (HCC) is the 2nd most common cause of cancer related death in Korea and well-known malignancy with poor prognosis. Sorafenib is the first-line molecular targeted agent in patients with extra-hepatic spread of HCC. However, complete response is extremely rare in patients treated with sorafenib and the disease control rate is only 43%. We report a 53-year-old man with advanced HCC with pulmonary metastasis who showed complete response by cytotoxic chemotherapy with doxorubicin and cisplatin with relatively tolerable adverse effects after failure of treatment with sorafenib. (J Liver Cancer 2017;17:72-76)